H.I.G. BioHealth Partners
Growth equityGrowth–Late Stage · 6 people tracked
Investment thesis
The firm invests in growth-stage healthcare businesses with the aim of improving patient outcomes while reducing overall healthcare costs. Its investment team brings experience across pharmaceuticals, biotech, medical devices, diagnostics, and related services. Leveraging the broader H.I.G. platform of over 500 investment professionals across 18 global offices, the fund provides operational value-creation support to mid-sized companies, partnering with founders and management teams to drive operational improvements and build market-leading positions.
Source: firm website, verified Aug 3, 2026.
Team · 6 people
from the firm's websiteInvestments · 2 tracked
founders shown can be your intro pathFrequently asked questions
- What stage does H.I.G. BioHealth Partners invest at?
- H.I.G. BioHealth Partners invests at the Growth, Late Stage stages.
- What sectors does H.I.G. BioHealth Partners focus on?
- H.I.G. BioHealth Partners focuses on Biotech, Digital Health, Healthtech, Medical Devices.
Images
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
B Capital Group is a multi-stage venture capital firm that backs founders across the company-building lifecycle, investing in technology, healthcare, and energy & resilience sectors.
Capricorn Partners is an independent manager of venture capital funds and Quest for Growth, backing innovative companies that use technology as a competitive advantage.
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
GV (formerly Google Ventures) is a venture capital firm backing companies across AI applications, healthcare, developer tools and security, and infrastructure.